I. Ceyla Et Al. , "Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease," JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315, pp.120-122, 2012
Ceyla, I. Et Al. 2012. Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315 , 120-122.
Ceyla, I., Tuba, T. K., Esra, A., Banu, O., Isil, F., Ali, G. M., ... Turgut, I.(2012). Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315, 120-122.
Ceyla, Irkec Et Al. "Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease," JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315, 120-122, 2012
Ceyla, Irkec Et Al. "Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease." JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315, pp.120-122, 2012
Ceyla, I. Et Al. (2012) . "Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease." JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.315, pp.120-122.
@article{article, author={Irkec Ceyla Et Al. }, title={Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease}, journal={JOURNAL OF THE NEUROLOGICAL SCIENCES}, year=2012, pages={120-122} }